New findings argue against a direct causal role for dopamine during the experience of a treatment effect in the establishment of positive treatment expectations and placebo analgesia in healthy volunteers, according to a study published September 24th in the open-access journal PLOS Biology by Ulrike Bingel from University Hospital Essen, Germany, and colleagues.
MASCT by Hengrui Yuanzheng Biotechnology for Soft Tissue Sarcoma: Likelihood of Approval
MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Soft Tissue Sarcoma.